drugset
drugset / Trial / NCT05098886

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

NCT05098886 ↗

Phase 1 Completed 36 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Phamacokinetics and safety profiles of DA-5210 10/1000mg in Healthy subjects at Fed State

Timeline

Start
2021-11-07
Primary completion
2022-01-04
Completion
2022-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5210 Unknown — —
Subject DA-5210-R Unknown — —

Indications

No indication recorded.